SAFETY AND EFFICACY OF LONG-TERM ASENAPINE VERSUS OLANZAPINE IN SCHIZOPHRENIA OR SCHIZOAFFECTIVE DISORDER PATIENTS

被引：0
|
作者：
Schoemaker, J. [1 ]
Naber, D. [2 ]
Jansen, W. [1 ]
Panagides, J. [3 ]
Emsley, R. [4 ]
机构：
[1] Schering Corp, Oss, Netherlands
[2] Univ Hamburg Eppendorf, Hamburg, Germany
[3] Schering Corp, Summit, NJ USA
[4] Univ Stellenbosch, Cape Town, South Africa
来源：
EUROPEAN PSYCHIATRY | 2010年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of long-term asenapine versus olanzapine in schizophrenia or schizoaffective disorder patients
    Schoemaker, J.
    Stet, L.
    Naber, D.
    Panagides, J.
    Emsley, R.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 238 - 238
  • [2] Long-Term Efficacy and Safety of Asenapine or Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder: An Extension Study
    Schoemaker, J.
    Stet, L.
    Vrijland, P.
    Naber, D.
    Panagides, J.
    Emsley, R.
    [J]. PHARMACOPSYCHIATRY, 2012, 45 (05) : 196 - 203
  • [3] Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder
    Schoemaker, J.
    Naber, D.
    Vrijland, P.
    Panagides, J.
    Emsley, R.
    [J]. PHARMACOPSYCHIATRY, 2010, 43 (04) : 138 - 146
  • [4] Long-Term Assessment of Asenapine vs. Olanzapine in Patients with Schizophrenia or Schizoaffective Disorder (vol 43, pg 138, 2010)
    Schoemaker, J.
    Naber, D.
    Vrijland, P.
    Panagides, J.
    Emsley, R.
    [J]. PHARMACOPSYCHIATRY, 2011, 44 (07) : 343 - 343
  • [5] Safety and efficacy of olanzapine long-acting injection for up to 6 years in patients with schizophrenia or schizoaffective disorder
    McDonnell, D. P.
    Detke, H. C.
    Choukour, M.
    Landry, J.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2012, 22 : S319 - S320
  • [6] Risperidone versus olanzapine in the treatment of patients with schizophrenia or schizoaffective disorder
    Brecher, M
    [J]. SCHIZOPHRENIA RESEARCH, 1999, 36 (1-3) : 271 - 271
  • [7] Olanzapine versus haloperidol in the treatment of schizoaffective disorder - Acute and long-term therapy
    Tran, PV
    Tollefson, GD
    Sanger, TM
    Lu, YL
    Berg, PH
    Beasley, CM
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 1999, 174 : 15 - 22
  • [8] Risperidone versus olanzapine in schizophrenia or schizoaffective disorder
    Conley, R
    Brecher, M
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 37S - 37S
  • [9] Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study
    Kwon, Jun Soo
    Jang, Joon Hwan
    Kang, Do-Hyung
    Yoo, So Young
    Kim, Yong Ku
    Cho, Seong-Jin
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2009, 63 (01) : 73 - 81
  • [10] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
12345